Skip to main content
Clinical Trials/NCT05813834
NCT05813834
Completed
Not Applicable

US-guided Genicular Nerves Block for Pain Control After Arthroscopic Anterior Cruciate Ligament Repair: A Prospective, Double Blinded, Randomized Controlled Study

Cairo University1 site in 1 country56 target enrollmentJune 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Genicular Nerve Block for Pain in ACL Arthroscopy
Sponsor
Cairo University
Enrollment
56
Locations
1
Primary Endpoint
post operative VAS
Status
Completed
Last Updated
last year

Overview

Brief Summary

Most of arthroscopic ACL repairs are day case surgeries associated with moderate postoperative pain and discomfort. So , finding an effective and safe, analgesic technique with minimal complications is our goal for fast recovery and short hospital stay.

in this study, we aim to compare the efficacy of genicular nerve block against controls on postoperative pain scores, the need for rescue analgesics, patient's satisfaction and range of motion (ROM) after arthroscopic ACL cases.

Detailed Description

In this study, we aim to compare the efficacy of genicular nerve block against controls on postoperative pain scores, the need for rescue analgesics, patient's satisfaction and range of motion (ROM) after arthroscopic ACL cases.

Registry
clinicaltrials.gov
Start Date
June 1, 2023
End Date
March 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dalia Ismail

Associate Professor of Anesthesia, Surgical ICU and pain management at Faculty of medicine Cairo University

Cairo University

Eligibility Criteria

Inclusion Criteria

  • both genders
  • age 18 - 65
  • ASA i, ii, iii

Exclusion Criteria

  • ROM less than 90
  • advanced renal or liver diseases
  • patient refusal
  • substance abuse
  • site infection
  • known sensitivity to any of study drugs

Outcomes

Primary Outcomes

post operative VAS

Time Frame: 24 hours

vas score

Secondary Outcomes

  • time to first morphine analgesia(24 hours)
  • total morphine consumption(24 hours)
  • range of motion(24 hours)
  • post operative MAP(24 hours)

Study Sites (1)

Loading locations...

Similar Trials